Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Diego, CA
SEC filing record 1 source field available
Fiscal year end
31 December
ACADIA PHARMACEUTICALS INC has filed 1,369 SEC EDGAR filings since 21 Dec 2000

SEC filing history

Showing 851-875 of 1,000 matching filings.

Per page
25
Current page
35
8-K File 000-50768

8-K filing

Filing date
07 May 2013
Reporting date
07 May 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
03 May 2013
Reporting date
01 May 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 000-50768

AUTO-GENERATED PAPER DOCUMENT

Filing date
26 Apr 2013
Reporting date
31 Dec 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 000-50768

DEF 14A

Filing date
25 Apr 2013
Reporting date
07 Jun 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
24 Apr 2013
Reporting date
22 Apr 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 Apr 2013
Reporting date
15 Apr 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 Apr 2013
Reporting date
16 Apr 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 Apr 2013
Reporting date
11 Apr 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 Apr 2013
Reporting date
11 Apr 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50768

8-K filing

Filing date
11 Apr 2013
Reporting date
11 Apr 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
03 Apr 2013
Reporting date
01 Apr 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
03 Apr 2013
Reporting date
01 Apr 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
03 Apr 2013
Reporting date
02 Apr 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
03 Apr 2013
Reporting date
01 Apr 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 000-50768

8-K/A filing

Filing date
21 Mar 2013
Reporting date
20 Mar 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50768

8-K filing

Filing date
21 Mar 2013
Reporting date
20 Mar 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50768

8-K filing

Filing date
12 Mar 2013
Reporting date
12 Mar 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
22 Feb 2013
Reporting date
21 Feb 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-80011

AMENDMENT NO. 1 TO SCHEDULE 13G

Filing date
14 Feb 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-80011

SCHEDULE 13G (AMENDMENT NO. 1)

Filing date
14 Feb 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-80011

SC 13G/A

Filing date
14 Feb 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-80011

ACADIA PHARMACEUTICALS

Filing date
13 Feb 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50768

8-K filing

Filing date
24 Jan 2013
Reporting date
18 Jan 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
23 Jan 2013
Reporting date
18 Jan 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .